L. Verburg

Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.

J. Blondal, K. Lee, J. Johnston, 1992, Leukemia research.

Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.

K. Lee, J. Johnston, L. Israels, 1995, Leukemia.

Role of transforming growth factor-beta in chronic lymphocytic leukemia.

S. Israels, J. Johnston, L. Israels, 1993, Leukemia research.

P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.

K. Lee, J. Johnston, L. Israels, 1997, Leukemia & lymphoma.

Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2′-deoxycoformycin and deoxyadenosine

J. Johnston, L. Israels, L. Verburg, 2004, Cancer Chemotherapy and Pharmacology.

Combination therapy with nucleoside analogs and alkylating agents.

J. Johnston, L. Israels, M. Williams, 1994, Leukemia.

Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia.

G. Goldenberg, J. Johnston, L. Israels, 1990, Journal of the National Cancer Institute.

Prevention of insulin-dependent diabetes mellitus by 2'-deoxycoformycin in the BB Wistar rat.

J. Johnston, N. Kobrinsky, L. Verburg, 1993, Biochemical pharmacology.